Quick Dispatch:
Your case report aspiration anesthesia semaglutide 2023 Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your case report aspiration anesthesia semaglutide 2023 Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement ships.
Need Help?
Questions about case report aspiration anesthesia semaglutide 2023 Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for case report aspiration anesthesia semaglutide 2023 Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement in your area.
GLP-1 Medication Disclosure Before Anesthesia: Essential Pre-Surgery Guide
27.16
New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review
23.58
As more patients use #semaglutide, rare but serious adverse effects are emerging for GLP-1 receptor agonists. JAMA #MedicalNews reports
21.28
Aspiration risk with glucagon‐like peptide 1 (GLP‐1) agonists - Marroquin‐Harris - 2023 - Anaesthesia
24.96
Glucagon-Like Peptide 1 Receptor Agonists and Aspiration Risk
22.82
Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study
24.56
Concerns have been raised about whether the delayed gastric emptying caused by GLP-1–based medications might jeopardize patient safety during procedures that require sedation. A randomized trial takes a closer look
28.84
